Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023)

Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023)

IntroductionRetinal vein occlusion (RVO) often causes irreversible visual impairment, making early prevention crucial. This study aims to identify associations between different medications and RVO and provide information for clinical practice.MethodThis study included reports of RVO from the FDA Ad...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao-Dong Chen, Kun-Hong Xiao, Chao-Bing Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Pharmacology
Subjects:
retinal vein occlusion
FDA adverse event reporting system
disproportionality analysis
pharmacovigilance
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1480269/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1480269/full

Similar Items